The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with lanthanum carbonate
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
456
Change in pre-dialysis serum phosphate levels at Week 3 compared with Week 5
Time frame: Week 3 and Week 5
Treatment emergent adverse events
Time frame: Throughout the study period of approximately 20 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.